SCHEMBL16615346

SCHEMBL16615346

CCN1CCC(c2nc(-c3c4c5c(n3-4)NCCN5Cc3c(Cl)ccc(F)c3Cl)no2)CC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.35
SMN1; SMN2 Q16637 4/20 0.35
GAA P10253 2/20 0.35
LMNA P02545 4/20 0.35
CLPP Q16740 1/20 0.34
CNR2 P34972 4/20 0.32
TLR9 Q9NR96 1/20 0.32
TLR8 Q9NR97 1/20 0.32
TLR7 Q9NYK1 1/20 0.32
HTT P42858 4/20 0.31
PRCP P42785 4/20 0.31
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31
CNR1 P21554 2/20 0.31
MEN1 O00255 1/20 0.31
MAPT P10636 1/20 0.31
KMT2A Q03164 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
KCNH2 Q12809 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16615312 0.84 NR1H4 (0.36) KMT2A
SCHEMBL16615365 0.78 PLK4 (0.35) MAPTKCNH2ALDH1A1
SCHEMBL16615313 0.77 PLK4 (0.36)
SCHEMBL16615200 0.76 CHRM1 (0.45) SMN1; SMN2NPC1RAB9A
SCHEMBL17918688 0.71 NR1H4 (0.37) TSHRSMN1; SMN2GAACLPPPRCP
SCHEMBL16615167 0.71 MAP4K3 (0.31)
SCHEMBL16615309 0.69 ALK (0.40) TSHRSMN1; SMN2GAACNR2TLR9
SCHEMBL16615279 0.69 HDAC1 (0.33)
SCHEMBL17969745 0.69 KDM4E (0.39) TSHRCNR2MAPTALDH1A1
SCHEMBL16615086 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015047133-A1 NOVEL CHEMICAL COMPOUNDS (VARIANTS) AND THE USE THEREOF TO TREAT ONCOLOGICAL DISEASES ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "ОТЕЧЕСТВЕННЫЕ ФАРМАЦЕВТИЧЕСКИЕ ТЕХНОЛОГИИ" 2015-04-02 WO disclosed